HLA-DR + CD38 + CD4 + T lymphocytes have elevated CCR5 expression and produce the majority of R5-tropic HIV-1 RNA in vivo

Journal of Virology

Volumn 85, Issue 19, 2011, Pages 10189-10200

  Meditz, Amie L ^a   Haas, Michelle K ^a,e   Folkvord, Joy M ^a   Melander, Kelsey ^a   Young, Russ ^a   McCarter, Martin ^b   MaWhinney, Samantha ^b   Campbell, Thomas B ^a   Lie, Yolanda ^c   Coakley, Eoin ^c,f   Levy, David N ^d   Connick, Elizabeth ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c MONOGRAM BIOSCIENCES   (United States)

^d NEW YORK UNIVERSITY   (United States)

^e BOTSWANA UPENN PARTNERSHIP   (Botswana)

^f ABBOTT LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD38 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; GREEN FLUORESCENT PROTEIN; HLA DR ANTIGEN; PHYTOHEMAGGLUTININ; VIRUS DNA; VIRUS RNA;

ARTICLE; CD4+ T LYMPHOCYTE; CELL STIMULATION; CONTROLLED STUDY; HLA DR+ CD38+ CD4+ T LYMPHOCYTE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LYMPH NODE CELL; LYMPHOCYTE COUNT; LYMPHOCYTE FUNCTION; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RNA SYNTHESIS; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; VIROGENESIS; VIRUS LOAD; VIRUS REPLICATION;

ADULT; ANTIGENS, CD38; ANTIGENS, CD4; FEMALE; HIV-1; HLA-DR ANTIGENS; HUMANS; LYMPH NODES; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; RECEPTORS, CCR5; RECEPTORS, HIV; RNA, VIRAL; T-LYMPHOCYTE SUBSETS;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 80053968742     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02529-10     Document Type: Article

References (51)

1. Begaud, E., et al. 2006. Reduced CD4 T cell activation and in vitro susceptibility to HIV-1 infection in exposed uninfected Central Africans. Retrovirology 3:35.
2. Biancotto, A., et al. 2007. Abnormal activation and cytokine spectra in lymph nodes of people chronically infected with HIV-1. Blood 109:4272-4279.
3. Biancotto, A., et al. 2008. HIV-1 induced activation of CD4+ T cells creates new targets for HIV-1 infection in human lymphoid tissue ex vivo. Blood 111:699-704.
4. Bleul, C. C., L. Wu, J. A. Hoxie, T. A. Springer, and C. R. Mackay. 1997. The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes. Proc. Natl. Acad. Sci. U. S. A. 94:1925-1930.
5. Chaudhry, A., et al. 2009. HIV-1 Nef promotes endocytosis of cell surface MHC class II molecules via a constitutive pathway. J. Immunol. 183:2415-2424.
6. Choudhary, S. K., et al. 2005. R5 human immunodeficiency virus type 1 infection of fetal thymic organ culture induces cytokine and CCR5 expression. J. Virol. 79:458-471.
7. Choudhary, S. K., et al. 2007. Low immune activation despite high levels of pathogenic human immunodeficiency virus type 1 results in long-term asymptomatic disease. J. Virol. 81:8838-8842.
8. de Baar, M. P., et al. 1999. Design and evaluation of a human immunodeficiency virus type 1 RNA assay using nucleic acid sequence-based amplification technology able to quantify both group M and O viruses by using the long terminal repeat as target. J. Clin. Microbiol. 37:1813-1818.
9. Deeks, S. G., et al. 2004. Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load. Blood 104:942-947.
10. Doitsh, G., et al. 2010. Abortive HIV infection mediates CD4 T cell depletion and inflammation in human lymphoid tissue. Cell 143:789-801.
11. Folks, T. M., et al. 1988. Characterization of a promonocyte clone chronically infected with HIV and inducible by 13-phorbol-12-myristate acetate. J. Immunol. 140:1117-1122.
12. Folkvord, J. M., C. Armon, and E. Connick. 2005. Lymphoid follicles are sites of heightened human immunodeficiency virus type 1 (HIV-1) replication and reduced antiretroviral effector mechanisms. AIDS Res. Hum. Retroviruses 21:363-370.
13. Ganusov, V. V., and R. J. De Boer. 2007. Do most lymphocytes in humans really reside in the gut? Trends Immunol. 28:514-518.
14. Giorgi, J. V., and R. Detels. 1989. T-cell subset alterations in HIV-infected homosexual men: NIAID Multicenter AIDS cohort study. Clin. Immunol. Immunopathol. 52:10-18.
15. Giorgi, J. V., et al. 1999. Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J. Infect. Dis. 179:859-870.
16. Giorgi, J. V., et al. 1993. Elevated levels of CD38+ CD8+ T cells in HIV infection add to the prognostic value of low CD4+ T cell levels: results of 6 years of follow-up. The Los Angeles Center, Multicenter AIDS Cohort Study. J. Acquir. Immune Defic. Syndr. 6:904-912.
17. Goldsmith, M. A., M. T. Warmerdam, R. E. Atchison, M. D. Miller, and W. C. Greene. 1995. Dissociation of the CD4 downregulation and viral infectivity enhancement functions of human immunodeficiency virus type 1 Nef. J. Virol. 69:4112-4121.
18. Gougeon, M. L., et al. 1996. Programmed cell death in peripheral lymphocytes from HIV-infected persons: increased susceptibility to apoptosis of CD4 and CD8 T cells correlates with lymphocyte activation and with disease progression. J. Immunol. 156:3509-3520.
19. Hazenberg, M. D., et al. 2003. Persistent immune activation in HIV-1 infection is associated with progression to AIDS. AIDS 17:1881-1888.
20. Howe, R., et al. 2009. Phenotypic and functional characterization of HIV-1-specific CD4+CD8+ double-positive T cells in early and chronic HIV-1 infection. J. Acquir. Immune Defic. Syndr. 50:444-456.
21. Hunt, P. W., et al. 2008. Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy. J. Infect. Dis. 197:126-133.
22. Karlsson, I., et al. 2005. Differential pathogenesis of primary CCR5-using human immunodeficiency virus type 1 isolates in ex vivo human lymphoid tissue. J. Virol. 79:11151-11160.
23. Kestens, L., et al. 1994. Selective increase of activation antigens HLA-DR and CD38 on CD4+ CD45RO+ T lymphocytes during HIV-1 infection. Clin. Exp. Immunol. 95:436-441.
24. Koning, F. A., et al. 2005. Low-level CD4+ T cell activation is associated with low susceptibility to HIV-1 infection. J. Immunol. 175:6117-6122.
25. Kutsch, O., E. N. Benveniste, G. M. Shaw, and D. N. Levy. 2002. Direct and quantitative single-cell analysis of human immunodeficiency virus type 1 reactivation from latency. J. Virol. 76:8776-8786.
26. Laurence, J., M. B. Sellers, and S. K. Sikder. 1989. Effect of glucocorticoids on chronic human immunodeficiency virus (HIV) infection and HIV promoter-mediated transcription. Blood 74:291-297.
27. Lee, B., M. Sharron, L. J. Montaner, D. Weissman, and R. W. Doms. 1999. Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages. Proc. Natl. Acad. Sci. U. S. A. 96:5215-5220.
28. Levy, D. N., G. M. Aldrovandi, O. Kutsch, and G. M. Shaw. 2004. Dynamics of HIV-1 recombination in its natural target cells. Proc. Natl. Acad. Sci. U. S. A. 101:4204-4209.
29. Lin, Y. L., et al. 2002. Cell surface CCR5 density determines the postentry efficiency of R5 HIV-1 infection. Proc. Natl. Acad. Sci. U. S. A. 99:15590-15595.
30. Liu, Z., et al. 1997. Elevated CD38 antigen expression on CD8+ T cells is a stronger marker for the risk of chronic HIV disease progression to AIDS and death in the Multicenter AIDS Cohort Study than CD4+ cell count, soluble immune activation markers, or combinations of HLA-DR and CD38 expression. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 16:83-92.
31. Maenetje, P., et al. 2010. A steady state of CD4+ T cell memory maturation and activation is established during primary subtype C HIV-1 infection. J. Immunol. 184:4926-4935.
32. Meditz, A. L., et al. 2008. SDF-1alpha is a potent inducer of HIV-1-specific CD8+ T-cell chemotaxis, but migration of CD8+ T cells is impaired at high viral loads. AIDS Res. Hum. Retroviruses 24:977-985.
33. Morner, A., et al. 1999. Primary human immunodeficiency virus type 2 (HIV-2) isolates, like HIV-1 isolates, frequently use CCR5 but show promiscuity in coreceptor usage. J. Virol. 73:2343-2349.
34. Murray, S. M., et al. 2010. Reduction of immune activation with chloroquine therapy during chronic HIV infection. J. Virol. 84:12082-12086.
35. Nokta, M. A., et al. 2001. Chemokine/CD4 receptor density ratios correlate with HIV replication in lymph node and peripheral blood of HIV-infected individuals. AIDS 15:161-169.
36. Platt, E. J., K. Wehrly, S. E. Kuhmann, B. Chesebro, and D. Kabat. 1998. Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1. J. Virol. 72:2855-2864.
37. Read, S. W., et al. 2010. The effect of leflunomide on cycling and activation of T-cells in HIV-1-infected participants. PLoS One 5:e11937.
38. Reeves, J. D., et al. 2002. Sensitivity of HIV-1 to entry inhibitors correlates with envelope/coreceptor affinity, receptor density, and fusion kinetics. Proc. Natl. Acad. Sci. U. S. A. 99:16249-16254.
39. Reynes, J., et al. 2001. CD4 T cell surface CCR5 density as a host factor in HIV-1 disease progression. AIDS 15:1627-1634.
40. Rouet, F., et al. 2005. Transfer and evaluation of an automated, low-cost real-time reverse transcription-PCR test for diagnosis and monitoring of human immunodeficiency virus type 1 infection in a West African resourcelimited setting. J. Clin. Microbiol. 43:2709-2717.
41. Saba, E., et al. 2010. HIV-1 sexual transmission: early events of HIV-1 infection of human cervico-vaginal tissue in an optimized ex vivo model. Mucosal Immunol. 3:280-290.
42. Schacker, T., et al. 2001. Productive infection of T cells in lymphoid tissues during primary and early human immunodeficiency virus infection. J. Infect. Dis. 183:555-562.
43. Schindler, M., et al. 2003. Down-modulation of mature major histocompatibility complex class II and up-regulation of invariant chain cell surface expression are well-conserved functions of human and simian immunodeficiency virus nef alleles. J. Virol. 77:10548-10556.
44. Sodora, D. L., and G. Silvestri. 2008. Immune activation and AIDS pathogenesis. AIDS 22:439-446.
45. Spiegel, H., H. Herbst, G. Niedobitek, H. D. Foss, and H. Stein. 1992. Follicular dendritic cells are a major reservoir for human immunodeficiency virus type 1 in lymphoid tissues facilitating infection of CD4+ T-helper cells. Am. J. Pathol. 140:15-22.
46. Stumptner-Cuvelette, P., et al. 2001. HIV-1 Nef impairs MHC class II antigen presentation and surface expression. Proc. Natl. Acad. Sci. U. S. A. 98:12144-12149.
47. Tenner-Racz, K., and P. Racz. 1995. Follicular dendritic cells initiate and maintain infection of the germinal centers by human immunodeficiency virus. Curr. Top. Microbiol. Immunol. 201:141-159.
48. Wang, J. M., et al. 1998. HIV-1 envelope gp120 inhibits the monocyte response to chemokines through CD4 signal-dependent chemokine receptor down-regulation. J. Immunol. 161:4309-4317.
49. Yang, O. O., et al. 2005. Effects of HIV-1 infection on lymphocyte phenotypes in blood versus lymph nodes. J. Acquir. Immune Defic. Syndr. 39:507-518.
50. Zhang, Z., et al. 1999. Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells. Science 286:1353-1357.
51. Zhang, Z. Q., et al. 2004. Roles of substrate availability and infection of resting and activated CD4+ T cells in transmission and acute simian immunodeficiency virus infection. Proc. Natl. Acad. Sci. U. S. A. 101:5640-5645.